ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express

08/14

Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:

• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026. • Considering the declaration of an interim dividend, if any.

The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1157826009"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157826009\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157826009?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157826009","market":"us","top_or_hot":-1,"title":"ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend","media":"Bulletin Express","content":"<p>Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03737","symbol_name":"中智药业","start_time":0,"source_url":"","article_id":"1157826009","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157826009","pubTimestamp":1786699669,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes: • Reviewing and approving the unaudited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03737":"中智药业"},"translate_title":"中植医药定于 2026 年 8 月 26 日召开董事会会议，审查 2026 年上半年业绩和中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03737":1},"content_text":"Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:\n• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.\nThe notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}